How common are pharmacokinetic and pharmacodynamic abnormalities in patients with severe asthma?

被引：0
|
作者：
Spahn, J. [1 ]
Doshi, J. [1 ]
Brown, E. [1 ]
Covar, R. [1 ]
机构：
[1] Univ Colorado, Natl Jewish Med & Res Ctr, Denver, CO USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2008年 / 121卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2007.12.1031
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1005
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe Asthma
    Ly, Neang
    Zheng, Yanan
    Griffiths, Janet M.
    Merwe, Rene
    Agoram, Balaji
    Parnes, Jane R.
    Roskos, Lorin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (07): : 901 - 912
  • [2] Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma
    Matera, Maria Gabriella
    Rogliani, Paola
    Calzetta, Luigino
    Cazzola, Mario
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (02) : 239 - 245
  • [3] Functional and immunological abnormalities in patients with severe asthma
    Kharevich, Olga
    Lapteva, Irina
    Lapteva, Elena
    Koroleva, Elena
    Shpakouskaya, Natalia
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [4] Pharmacokinetic–Pharmacodynamic–Efficacy Analysis of Efalizumab in Patients with Moderate to Severe Psoriasis
    Chee M. Ng
    Amita Joshi
    Russell L. Dedrick
    Marvin R. Garovoy
    Robert J. Bauer
    Pharmaceutical Research, 2005, 22 : 1088 - 1100
  • [5] A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity
    Heetla, H. W.
    Proost, J. H.
    Molmans, B. H.
    Staal, M. J.
    van Laar, T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (01) : 101 - 112
  • [6] Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis
    Macias, WL
    Dhainaut, JF
    Yan, SCB
    Helterbrand, JD
    Seger, M
    Johnson, G
    Small, DS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (04) : 391 - 402
  • [7] Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis
    Ng, CM
    Joshi, A
    Dedrick, RL
    Garovoy, MR
    Bauer, RJ
    PHARMACEUTICAL RESEARCH, 2005, 22 (07) : 1088 - 1100
  • [8] Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma
    Matera, Maria Gabriella
    Calzetta, Luigino
    Rinaldi, Barbara
    Cazzola, Mario
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (09) : 1007 - 1013
  • [9] PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF TERBUTALINE BRONCHODILATION IN ASTHMA
    OOSTERHUIS, B
    BRAAT, MCP
    ROOS, CM
    WEMER, J
    VANBOXTEL, CJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (04) : 469 - 475
  • [10] ELECTROCARDIOGRAPHIC ABNORMALITIES IN SEVERE ASTHMA
    GELB, AF
    LYONS, HA
    FAIRSHTER, RD
    GLAUSER, FL
    MORRISSEY, R
    CHETTY, K
    SCHIFFMAN, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1979, 63 (03) : 170 - 171
12345